Back to Search
Start Over
Dupilumab efficacy and biomarkers in chronic rhinosinusitis with nasal polyps: Association between dupilumab treatment effect on nasal polyp score and biomarkers of type 2 inflammation in patients with chronic rhinosinusitis with nasal polyps in the phase 3 SINUS‐24 and SINUS‐52 trials
- Source :
-
International Forum of Allergy & Rhinology . Sep2022, Vol. 12 Issue 9, p1191-1195. 5p. - Publication Year :
- 2022
-
Abstract
- Correlations were interpreted as very weak (0.00-0.19), weak (0.20-0.39), moderate (0.40-0.59), or strong (0.60-0.79).10 RESULTS Baseline characteristics Baseline demographics, disease characteristics, and biomarkers (Supplementary Table 1) were balanced among treatment groups and were consistent with a population with severe CRSwNP. Further research is needed to determine which biomarkers of type 2 inflammation best correlate with disease-specific objective measures of severity and subjective patient-reported outcomes. [Extracted from the article]
Details
- Language :
- English
- ISSN :
- 20426976
- Volume :
- 12
- Issue :
- 9
- Database :
- Academic Search Index
- Journal :
- International Forum of Allergy & Rhinology
- Publication Type :
- Academic Journal
- Accession number :
- 158791336
- Full Text :
- https://doi.org/10.1002/alr.22964